HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
SAN FRANCISCO, May 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
- SAN FRANCISCO, May 24, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
- CareDx, Inc. (CDNA) Securities Fraud Class Action:
The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment. - If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
- Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.